太原市最好肛肠科医院(太原肛门松了怎么办) (今日更新中)

The Trump administration is promising one of the largest fireworks displays in recent memory in Washington on July Fourth. It also plans to give away as many as 300,000 face masks to those who come down to the National Mall for the festivities, although they won't be required to wear them. This is despite concerns from D.C. Mayor Muriel Bowser, who warns that the plans run counter to established health guidelines. Interior Secretary David Bernhardt on Wednesday detailed President Donald Trump's plans for Independence Day in the nation's capital and said they include a mile-long detonation of 10,000 fireworks. Trump and first lady Melania Trump plan to host events on Saturday from the White House south lawn and from the Ellipse.Additionally, military planes will conduct flyovers in a handful of major cities along the East Coast as part of this year’s July Fourth celebration. The Pentagon says roughly 1,700 service members will support a salute to the “Great Cities of the American Revolution.” The flyovers will begin in Boston and proceed to New York City, Philadelphia and Baltimore. Washington has held an Independence Day celebration for decades, featuring a parade along Constitution Avenue, a concert on the Capitol lawn with music by the National Symphony Orchestra and fireworks beginning at dusk near the Washington Monument.President Donald Trump plans to kick off Independence Day festivities with a showy display at Mount Rushmore the day before. When he speaks at the Mount Rushmore, he’ll stand before a crowd of thousands of people who won't be required to socially distance or wear masks despite the coronavirus pandemic. The event will include fighter jets thundering over the 79-year-old stone monument in South Dakota’s Black Hills and the first fireworks display there since 2009.Public health experts are warning of the risk that it could help the coronavirus to spread. And others say the fireworks will put the forest around the monument at risk to wildfires. 2003

The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough.The Food and Drug Administration may have to decide by year’s end whether to allow use of the first vaccines against the virus. Thursday, a federal advisory committee pulls back the curtain on that decision process, debating whether the guidelines FDA has set for vaccine developers are rigorous enough.“We will not cut corners, and we will only use science and data to make that determination,” FDA Commissioner Stephen Hahn pledged at a meeting of the Milken Institute Wednesday.Exactly how much data his agency needs to be sure a vaccine is safe and effective is a key question for the advisers. An even bigger one: If the FDA allows emergency use of a vaccine before final testing is finished, will that destroy chances of ever learning just how well that shot -- and maybe competitors still being studied -- really work?“We can’t lose sight of the fact that it is in our societal interest to see these trials to completion,” said Dr. Luciana Borio, a former FDA acting chief scientist who will be watching the advisers’ debate.Plus, multiple vaccines are being studied -- shots made with different technologies that each have pros and cons.“The first vaccine is not necessarily the best vaccine,” cautioned Dr. M. Miles Braun, a former FDA scientist now with Georgetown University School of Medicine. If the trials aren’t allowed to finish, it may be difficult or impossible to ever know for sure.It’s a critical moment in FDA’s 114-year history. The government has spent billions to race a vaccine through a research process that usually takes years, and FDA faces unprecedented pressure from the Trump administration, fueling public skepticism that politics could overrule science.Interest is so high, FDA is airing the meeting on YouTube. Here are some key issues the committee will discuss:HOW MUCH EVIDENCE IS NEEDED?FDA is requiring manufacturers to do studies of at least 30,000 people to prove if a vaccine protects and how safe it is. Those studies must include adequate numbers of people at highest risk from COVID-19 -- older adults, minorities and anyone with underlying health problems.FDA has made clear that any vaccine must be at least 50% effective. And while the studies are designed to run for two years, companies may get enough evidence the shots are protective -- in at least some people -- to stop the trials early and seek what’s called an “emergency use authorization” for wider vaccinations.Despite White House objections, the FDA told vaccine makers earlier this month not to seek that speedier review until they’ve tracked at least half their trial participants for two months. With other vaccines, that’s about the amount of time when major side effects crop up.That’s not long enough, said the head of the non-profit ECRI Institute, which reviews medical technology for hospitals and insurers. In comments submitted to the advisory committee, ECRI’s Dr. Marcus Schabacker said FDA should require six months of follow-up.“Doing any less would simply risk too much, and the consequences may be severe,” he wrote. “A weak vaccine that loses public trust could poison the well for epidemic control for many years.”WOULD EMERGENCY USE DERAIL FULL ANSWERS ABOUT VACCINES?Normally when a study ends because of evidence that a vaccine is working, the participants who got dummy shots are offered the real thing.But if FDA allows emergency use of a COVID-19 vaccine, that’s not the same as having full proof the shot works, Borio cautioned.And if the participants in the placebo group are immediately offered the real shot, researchers may not be able to get answers about all the high-risk groups in the study — or tell how long the vaccine’s protection lasts, a process expected to take many more months.But Pfizer Inc., which with Germany’s BioNTech is developing one of the leading candidates, told FDA that if it’s granted emergency use authorization, it “would have an ethical obligation” to alert study participants who got a placebo and allow them vaccine access. The company wants FDA to look into “other scientifically and statistically sound methods” to determine long-term safety and effectiveness.Pfizer’s stance is likely to face pushback. The Infectious Diseases Society of America states that FDA’s panelists “should insist” that vaccine developers “present a compelling case” for how they will complete their trials if FDA grants early authorization of their vaccine.Clearing a vaccine based on premature or faulty data “could cause more harm” by “further eroding public confidence in all vaccines,” the group said.It’s an unprecedented dilemma. The FDA has previously allowed emergency use of only one vaccine, a decades-old shot that in 2005 was authorized to prevent anthrax poisoning.This time around, multiple COVID-19 vaccines are in the pipeline. Pfizer competitor Johnson & Johnson cautioned that early FDA clearance of one vaccine could “jeopardize integrity” of other ongoing trials if patients decide to drop out to seek the first cleared shot instead.The company asked regulators to explain what options are available to ensure completion of all ongoing COVID-19 vaccine trials.WHAT ABOUT LONG-TERM SAFETY MONITORING?Even a study of 30,000 people cannot spot a side effect that only strikes 1 in 100,000. So the government is planning extra scrutiny of every COVID-19 vaccine to hit the market.At first there will be limited doses given to just certain high-risk people -- and those early recipients are to get text messages daily for the first week after vaccination, and then weekly out to six weeks, asking how they’re feeling.FDA also will be checking databases of electronic health records and insurance claims, looking for any red flags.“There’s a kind of tracking that has to take place here on a massive basis that hasn’t taken place before,” said Dr. Jesse Goodman of Georgetown University, a former director of the FDA’s vaccine and biologics center.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6274

The remains of Spc. Vanessa Guillen were found near the Leon River in Texas, bringing an end to the search for the Fort Hood soldier. The attorney for the Guillen family said last week that the family believed the human remains found Tuesday were those of Guillen but a positive identification was pending."The Army has identified the remains of missing Fort Hood soldier Vanessa Guillen," her family's lawyer said in a statement to ABC News on Sunday evening.On Monday, the Army Criminal Investigative Team confirmed the remains were of Guillen's. “I know I can speak for everyone involved in this tragic situation that we are truly heartbroken for the family, friends and fellow Soldiers of Spc. Guillen,” said Brigadier General Duane Miller, the acting commanding general of the U.S. Army Criminal Investigation Command. “There are no words that can express the sorrow and loss that the family has endured, but we hope in some very small way, the collective efforts of everyone involved in finding Vanessa and working to bring those responsible to justice will help bring some degree of closure to the family who has had to endure this painful and senseless loss.”The two suspects in her disappearance are Spc. Aaron Robinson and Cecily Anne Aguilar, a civilian.According to the affidavit, the suspects allegedly dismembered Guillen's body and attempted to burn it after she was bludgeoned to death by Spc. Robinson.Special Agents from the U.S. Army Criminal Investigation Command, along with the U.S. Marshals, Killeen Police Department, and the Lone Star Fugitive Task Force were attempting to locate Robinson on June 30 when he fled the post.When Robinson was located, officers attempted to make contact him as he produced a weapon and committed suicide by shooting himself. Aguilar has been arrested for tampering/ fabricating physical evidence with intent to impair a human corpse, a second degree felony. If conviction, Aguilar faces up to 20 years in federal prison and a maximum 0,000 fine.Guillén’s family said through their lawyer that they believe Vanessa was sexually harassed by the military suspect and is calling for a Congressional investigation.20-year-old Guillen was last seen on the morning of April 22 in the parking lot of her Regimental Engineer Squadron Headquarters, 3rd Cavalry Regiment on Fort Hood, Texas, and had not been heard from since that date.The Army Criminal Investigation Command has been working closely with multiple law enforcement agencies throughout this investigation to include the FBI, Belton Police Department, Bell County Sheriff’s Department, the United States Marshals Service, the Texas Rangers and the Texas Department of Public Safety.This article was written by Thalia Brionez for KXXV. 2754

The Swan Dive in Toronto was preparing to close at the beginning of December due to the pandemic, and with little to no revenue, the bar’s owner did not know how long the bar would be able to pay for its rent.Within days after announcing to the community that the bar would be forced to closed due to the pandemic, customers came and bought the bar’s entire stock of beers. Now it appears the bar, unlike many other small businesses in Toronto, will have a chance to reopen in the future.The Swan Dive now hopes to reopen in February, with occasional days as a to-go bottle shop between now and then."We were blowing through our savings and I wasn't sure if I was going to be able to pay rent towards the end of the month," bar owner Abra Shiner told CNN. "So, I wrote on Facebook asking people to come buy the beer we had in our stock room ... and it worked. The post went viral."Shiner told CNN that the sales coupled with government subsidies will allow the bar to survive until March. 996

The stock market had its worst day in a month as virus cases surge and help for the economy from Washington remains nowhere in sight. The S&P 500 fell 1.9% Monday, deepening its losses from last week. Stocks of companies that need the virus to abate and the economy to return to normal had some of the biggest losses. Cruise lines and airlines fell sharply. Energy stocks also dropped in tandem with crude oil prices. In another sign of caution, Treasury yields pulled back after touching their highest level since June last week. Overseas markets also fell.The drop in stock value came as coronavirus cases reached peak levels in the US over the weekend, while White House chief of staff Mark Meadows proclaimed that the US would be unable to contain the spread of the virus. 788

来源：资阳报